Immunotherapy is revolutionizing cancer treatment by empowering the body’s immune system to recognize and destroy cancer cells. For many advanced or resistant cancers—including lung, bladder, melanoma, kidney, lymphoma, and leukemia—immunotherapy offers not just extended survival, but sometimes lasting remission.

India has emerged as a destination of choice—offering globally recognized immunotherapies at a fraction of Western prices, supported by top-tier hospitals and leading oncologists. This comprehensive guide covers everything you need to know about immunotherapy costs, therapy types, success rates, and why patients from around the world choose India for treatment.

Understanding Immunotherapy and Its Variants

Immunotherapy refers to a range of treatments that boost or guide the immune system to target cancer cells effectively. Major classes include:

• Checkpoint inhibitors (e.g. nivolumab, pembrolizumab, atezolizumab)
• Monoclonal antibodies targeting tumor-specific antigens
• CAR T‑cell therapy (engineered T‑cells directed at cancer targets)
• Cancer vaccines designed to stimulate immune response
• Cytokines and immunomodulators that enhance immune activity
• Adoptive cell transfer and other personalized cell therapies 

India now offers all of these modalities, often under expert care and at significantly lower costs compared to western countries.

How Immunotherapy Works

These therapies work by:

• Blocking tumor-mediated immune suppression (via PD‑1/PD‑L1 or CTLA‑4 pathways)
• Genetically reprogramming a patient’s T-cells to attack cancer
• Enhancing immune cell proliferation or function with cytokines or drugs
• Training the body to recognize cancer-specific antigens 

Such treatments can lead to durable responses—even in metastatic disease—especially when guided by biomarkers like PD-L1 expression or mismatch repair status.

Why Choose India for Cancer Immunotherapy

• Substantial cost advantage over Western countries
• Modern treatment protocols and global-standard care
• Shorter waiting times, especially for urgent or advanced cases
• Multilingual support and medical tourism facilitators for international patients
• High-quality clinical infrastructure–PET-CT, in‑house labs, molecular diagnostics, clinical trial access
• Compassionate care models, especially in public institutions with subsidized pricing 

Planning Your Immunotherapy Journey

Pre-treatment Requirements:

• Biopsy confirmation and genomic profiling (e.g. PD-L1, TMB, MSI)
• PET‑CT/MRI/CT scans to stage disease
• Baseline blood tests and organ function evaluation
• Second opinion if needed
  

Treatment Scheduling:

• Most immunotherapy drugs are administered via IV infusion in daycare/OPD settings
• Patients need medical footing for side-effect monitoring
• Session frequency varies: weekly, every 2-week, monthly depending on drug
  

Monitoring & Follow‑Up:

• Periodic imaging (CT, PET) to assess response
• Regular blood tests to monitor organ function and immune-related effects
• Allergy or immune‑mediated adverse events managed through dexamethasone, antihistamines
  

Emotional & Financial Preparation:

• Emotional counseling and support for side effects or uncertainty
• Financial counseling to plan cycles, drug availability, and subsidies
• Engage with patient support groups or hospital social workers
  

Conclusion

Immunotherapy represents a transformative advancement in cancer treatment offering durable responses with fewer side effects. India delivers this cutting-edge care at significantly lower costs—with access to CAR‑T therapies, checkpoint inhibitors, vaccines, and personalized cell therapies. Top hospitals, global-quality diagnostics, and compassionate care models combine to make India a compelling choice for international patients seeking world-class cancer care on a budget.

India offers not just affordable pricing, but also state-of-the-art protocols, clinical trial access, and continuous patient support. Whether you’re exploring options in checkpoint therapy or advanced CAR‑T cell treatment, India provides therapeutic hope, emerging success, and a healing environment.

Top Hospitals for Immunotherapy Cost

Below are the list of the top hospitals that are known for Immunotherapy Cost procedures:

PSRI hospital, Saket

Established in: 1996

Number of Beds: 201

Multi Specialty

Location: Saket, New Delhi, India

Book Appointment

BLK Super Speciality Hospital

Established in: 1959

Number of Beds: 650+

Multi Specialty

Location: Gurugram

Book Appointment

Shalby Hospital, Ahmedabad

Established in: 1994

Multi-Specialty Hospital

Location: Ahmedabad

Book Appointment

Apollo Reach Hospital, Miryalaguda

Established in: 2022

Number of Beds: 100 Beds

Multi Specialty Hospital

Location: Miryalaguda, Hyderabad

Book Appointment

Apollo Athenaa Women’s Cancer Centre – Defence Colony, New Delhi

Established in: 2022

Number of Beds: 30+ Beds

Single Specialty Hospital

Location: Defence Colony, New Delhi, Delhi, India

Book Appointment

Fortis Hospital, Mulund, Mumbai

Established in: 2002

Number of Beds: 400+ Beds

Multi Specialty Hospital

Location: Mulund (West), Mumbai, Maharashtra, India

Book Appointment

MGM Hospital, chennai

Established in: 2016

Number of Beds: 400

Multi-Specialty Hospital

Location: Chennai

Book Appointment

Max Kalinga Hospital, Bhubaneswar

Established in: 1996

Number of Beds: 250+ Beds

Multi Super Specialty Hospital

Location: Bhubaneswar, Odisha

Book Appointment

Max Super Speciality Hospital, Vaishali

Established in: 2008

Number of Beds: 387+ Beds

Multi Specialty Hospital

Location: Vaishali, Ghaziabad

Book Appointment

Apollo Children’s Hospital, Chennai

Established in: 2009

Number of Beds: 70+ Beds

Multi Specialty Hospital

Location: Thousand Lights, Chennai, Tamil Nadu, India

Book Appointment

Top Immunotherapy Cost Specialists

Kidney Transplant Surgeon & Urologist View Profile

Dr. Rajinder Yadav

New Delhi, India

4.0

Experience: 42+ Years of Experience

Education: MBBS, MS (General Surgery), M.Ch (Urology, AIIMS New Delhi

Get a free consultancy

Book Appointment Chat on WhatsApp

Surgical Oncologist View Profile

Dr. Piyush Kumar Agarwal

Gurugram

4.0

Experience: 20

Education: MBBS, MS, M.Ch

Get a free consultancy

Book Appointment Chat on WhatsApp

Surgical Oncologist View Profile

Dr. Ashish Goel

Noida

4.0

Experience: 32

Education: MBBS , MS , DNB , MNAMS

Get a free consultancy

Book Appointment Chat on WhatsApp

Urologist View Profile

Dr. Mahendra Jain

Bengaluru, Karnataka, India

4.0

Experience: 31+ Years of Experience

Education: MBBS, MS, MCh, DNB

Get a free consultancy

Book Appointment Chat on WhatsApp

Surgical Oncologist View Profile

Dr. Niranjan Naik

Gurugram

4.0

Experience: 27+

Education: MBBS , MS , Fellowship

Get a free consultancy

Book Appointment Chat on WhatsApp

Surgical Oncology View Profile

Dr. Ravi Kant Arora

Faridabad, India

4.0

Experience: 28+ years of experience

Education: MBBS, MS, MCh

Get a free consultancy

Book Appointment Chat on WhatsApp

Obesity View Profile

Dr. Rashmi Pyasi

Gurgaon, New Delhi

4.0

Experience: 26+ years of experience

Education: Senior Consultant, MBBS, MS

Get a free consultancy

Book Appointment Chat on WhatsApp

Gynecologic Oncologist View Profile

Dr. Prerna Lakhwani

New Delhi, India

4.0

Experience: 17+ Years of experience

Education: MBBS, MS (Obstetrics & Gynecology), Advanced Training in Gynecologic Oncology

Get a free consultancy

Book Appointment Chat on WhatsApp

Surgical Oncologist View Profile

Dr. Shivam Vatsal Agarwal

Faridabad, India

4.0

Experience: 25+ Years of Experience

Education: MBBS , MS , Fellowship

Get a free consultancy

Book Appointment Chat on WhatsApp

Medical Oncologist View Profile

Dr. Sunny Garg

Gurugram, India

4.0

Experience: 16+

Education: MBBS, MD, DM

Get a free consultancy

Book Appointment Chat on WhatsApp

Treatment Costs in India

Factors Influencing Cost in India

Treatment costs in India vary depending on several major factors:

• Type of immunotherapy drug (e.g. checkpoint inhibitor vs CAR‑T cell)
• Brand name vs biosimilar or Indian generic
• Frequency and total number of cycles
• Cancer type and stage (solid tumor vs hematologic malignancy)
• Diagnostic tests and biomarker profiling (e.g. PD‑L1, MSI, TMB)
• Hospital choice (private multispecialty, government institute, JCI/NABH accreditation)
• City or region (metro cities may charge more)
• Supportive medications, imaging, follow-up care
• Daycare vs inpatient setting depending on complications

How Much Does Immunotherapy Cost in India?

Single-Cycle Cost Estimates

Per cycle cost range in India:

• Checkpoint inhibitors: ₹80,000 – ₹150,000 (approx. $1,000–2,000)
• Monoclonal antibodies / targeted antibodies: ₹150,000 – ₹400,000
• Cancer vaccines or cytokines: ₹50,000 – ₹200,000
• Adoptive cell therapy (non‑CAR‑T): ₹300,000 – ₹700,000
• CAR T‑cell therapy (e.g. NexCAR19 in India): ₹30,00,000 – ₹60,00,000+
• Immunomodulators: ₹100,000 – ₹300,000 per cycle
  

Full Treatment Course (Multi-cycle)

Patients often require 4 to 12 cycles, depending on response and protocol. Total cost for a full course:

• Lower-end immunotherapy courses: ₹3,00,000 – ₹8,00,000
• Comprehensive checkpoint regimens (e.g., pembrolizumab/nivolumab): ₹10,00,000 – ₹45,00,000

CAR‑T Cell therapy course: ₹30,00,000 – ₹60,00,000+ depending on hospital and consumables

Breaking Down Additional Costs

Aside from drug charges, other expenses include:

• Consultation & oncology evaluations: ₹500 – ₹5,000 per visit
• Pre‑treatment scans (PET‑CT, MRI, CT): ₹5,000 – ₹40,000
• Diagnostic biopsy and blood tests: ₹1,000 – ₹30,000
• PD‑L1, MSI, TMB and genomic profiling: Usually ₹20,000–50,000+
• Support medications (steroids, anti-inflammatories): Variable, depending on side‑effects
• Daycare facility charges or brief hospitalization
  

Even factoring these in, the total cost is typically far lower than Western countries.

Frequently Asked Questions

FAQs

1. Who is eligible for immunotherapy?
   Patients with advanced or refractory cancers where targetable biomarkers (PD-L1, MSI, etc.) are positive; defined cancer types (melanoma, lung, bladder, lymphoma).
2. What is the typical success rate?
   Approximately 15–20% of patients achieve durable remission with checkpoint inhibitors; CAR T-cell therapy offers higher remission in eligible blood cancers (> 50% long-term in many centers)
3. Are generics or biosimilars available?
   Some biosimilars of pembrolizumab or nivolumab are being developed locally, offering reduced cost—though many hospitals still use branded drugs.
4. Can insurance cover immunotherapy?
   Increasingly yes; national schemes and private insurers cover drugs if approved. Pharma patient‑support programs also assist. Check your policy details.
5. What are common side effects?
   Mild flu-like symptoms, fatigue, rashes, organ inflammation (colitis, pneumonitis), endocrine dysfunction, blood count changes.
6. Can international patients access treatment easily?
   Yes—major hospitals offer medical visa support, transport coordination, interpreter services, and personalized case managers.
7. Is CAR T‑cell therapy available in India?
   Yes. Institutions like Tata Memorial and private hospitals offer CAR‑T therapy like NexCAR19 at ₹30–40 lakh, much lower than international cost (~₹3–4 crore).
8. Are there affordable options for low-income patients?
   Yes—government hospitals and charitable centres (Kidwai, Tata Memorial, RCC Thiruvananthapuram) offer subsidized or free treatment.

9. Are there any side effects of immunotherapy?

Yes, while immunotherapy is generally well-tolerated compared to chemotherapy, some patients may experience side effects such as:

• Fatigue
• Skin rash or itching
• Flu-like symptoms
• Inflammation in organs (lungs, liver, or intestines)
• Autoimmune reactions in rare cases
  These side effects are usually manageable with medications or by adjusting the therapy. 

10. How long does immunotherapy treatment last in India?

The duration of immunotherapy varies depending on your cancer type, treatment response, and tolerance. In many cases, treatment is given every 2 to 3 weeks over a course of 6 months to 2 years. Some patients may require long-term maintenance therapy if they continue to respond well.

11. Can international patients get immunotherapy treatment in India?

Absolutely. India is a leading medical tourism destination for cancer care, including immunotherapy. Top hospitals in cities like Delhi, Mumbai, Chennai, and Bengaluru offer world-class immunotherapy protocols at much lower costs compared to the US, UK, or Europe. International patients are provided with visa support, airport pick-up, multilingual coordinators, and post-treatment care assistance.